Kenneth Goodling

Kenneth Goodling serves as a key procurement lead within the National Institute on Drug Abuse (NIDA), supporting the agency’s mission to advance scientific research on substance use disorders through strategic acquisition of high-impact scientific and technical services. He manages a diverse portfolio of research-focused contracts, primarily facilitating the procurement of laboratory instrumentation, biomedical research services, and clinical translation initiatives. His work ensures that NIDA’s funded investigators have access to cutting-edge tools and analytical capabilities necessary for neurobiological and behavioral research, aligning acquisitions directly with the institute’s priority areas in addiction science and public health innovation. Goodling maintains strong, recurring relationships with leading academic and research institutions, including The McLean Hospital Corporation, the University of Maryland Baltimore, the University of Miami, the University of Pittsburgh, and the Icahn School of Medicine at Mount Sinai. These partnerships reflect a pattern of awarding long-term, project-based research contracts to institutions with demonstrated expertise in neuroscience, addiction treatment development, and clinical trial infrastructure. His procurement approach emphasizes collaboration with research-intensive organizations capable of delivering complex, multidisciplinary scientific outcomes. His contracting activity reflects a strong preference for open competition, with approximately 74% of awards issued without set-asides, while maintaining a consistent 25.8% allocation to total small business set-asides under FAR 19.5. This balance indicates a commitment to broad market access while intentionally supporting small business participation in high-skill scientific services, without prioritizing specific socioeconomic categories like 8(a) or HUBZone. Goodling’s primary procurement focus lies in NAICS 541715 (R&D in life sciences) and 334516 (analytical laboratory instrument manufacturing), with significant activity in electromedical apparatus (334510) and professional scientific services (541990). He regularly acquires specialized equipment for neuroimaging, drug metabolism analysis, and behavioral monitoring systems, reflecting deep technical expertise in supporting laboratory-to-clinic translational research in addiction science.